tirzepatide lawsuit 2025 🚨 URGENT: Being Pulled from the Market! 🚨 We've just received critical news—Tirzepatide will no longer be available after March 17th! Our compounding pharmacy has lost their lawsuit, meaning supplies will FDA's Removal of Semaglutide and

Clinical nutrition guidelines recommend that patients on weight loss therapy engage in regular physical activity and consume sufficient protein to help preserve muscle mass

GLP-1 analogs and their role in improving fertility outcomes in obese women undergoing IVF

This is normal, not a plateau

Clinica Chimica Acta

Phase 3: TRANSCEND-T2D-1 Results (May 2026) In May 2026, Eli Lilly released topline results from TRANSCEND-T2D-1, the first Phase 3 trial for retatrutide in adults with type 2 diabetes

Consistently, class I poplar GRXS12, which has an active site without a resolving cysteine, is almost 100% glutathionylated when purified from E